Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...

The National Pharmacy Association is calling for tougher rules in the market, saying people with a history of eating ...

“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are "concerned that the current regulations allow some patients to ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a new study has uncovered neurological and behavioral health ...

The National Pharmacy Association (NPA) has written to regulators calling for tougher rules over access to medications like ...